Vitamin C
Also sold as: Ascorbic acid · Ascorbate · Liposomal vitamin C
A water-soluble vitamin required for collagen synthesis and normal metabolism. Correcting deficiency is established; megadose immune and longevity claims exceed the clinical evidence.
Longevity Focus
Community
Not enough ratings yet: 0 of 10
Scores appear after 10 ratings, so that one or two reports can't dominate. Tried it? Your rating counts.
Research
- Focus: Low vitamin C status correlates with poorer cognition, but supplementation has not established dementia prevention or improved focus in replete adults.
- Longevity: Oral supplementation has not established cardiovascular-event or mortality prevention in generally nourished people.
REALITY CHECK // Regular vitamin C produces a small cold-duration benefit, not a general infection shield or a proven rescue dose after symptoms begin. Liposomal delivery can change plasma exposure modestly, but has not shown proportionately greater clinical benefit or reproduced IV concentrations.
Levels: how we grade evidence. Grey = evidence of no benefit; amber = evidence it makes this goal worse.
Ratings are self-reported by a self-selected group of users: how it felt, not proof that it works.
Check your bottle
Compare what your label says with what was used in trials. This is a trial range, not a personal prescription.
Enter the amount from your label to see the result.
How it was studied
UPPER LIMIT // US adult UL: 2000 mg/day total vitamin C, based mainly on diarrhea and gastrointestinal intolerance. The dossier reports no numerical EFSA UL; this does not mean unlimited dosing is safe. IV pharmacological treatment is outside this oral calculator.
Summary
Deficiency correction prevents or treats scurvy. Regular supplementation modestly shortens colds, about 8% in adults and 14% in children, but generally does not prevent them; starting after symptoms has no consistent effect. Oral products are not interchangeable with experimental IV treatment.
Mechanism
Ascorbate supports collagen hydroxylation, carnitine and catecholamine pathways, and reduces non-heme iron for absorption. Intestinal transport saturates, and renal regulation limits plasma exposure from oral doses.
Typical studied dose
Cold-prevention trials used at least 200 mg/day regularly; blood-pressure trials often used about 500 mg/day. One pharmacokinetic liposomal study used 500 mg. Training trials combined 1000 mg/day C with 235 mg/day E. These distinct exposures do not establish a megadose target.
Upper limit
US adult UL: 2000 mg/day total vitamin C, based mainly on diarrhea and gastrointestinal intolerance. The dossier reports no numerical EFSA UL; this does not mean unlimited dosing is safe. IV pharmacological treatment is outside this oral calculator.
Popular stacks with Vitamin C
Not enough stack data yet. A combination with Vitamin C appears here once 5 people rate the same set.
Forms and label traps
| Form on label | Active content | Studied range / day | Absorption & GI tolerance | Verdict |
|---|---|---|---|---|
| L-ascorbic acid Best for: Comparison with the exact ingredient and dose basis on the Supplement Facts panel. |
100% elemental / active | 200–500 mg | Vitamin C mass equals pure ascorbic-acid mass. Absorption is saturable; acidity and diarrhea can limit tolerance. The interval reflects selected oral cold and blood-pressure studies. See the form-specific clinical note; tolerance depends on dose and medical context. |
Studied standard [LABEL // VERIFY_DOSE_BASIS] Vitamin C mass equals pure ascorbic-acid mass. Absorption is saturable; acidity and diarrhea can limit tolerance. The interval reflects selected oral cold and blood-pressure studies. |
| Sodium ascorbate: raw salt mass Best for: Comparison with the exact ingredient and dose basis on the Supplement Facts panel. |
89% elemental / active | 200–500 mg | Approximately 89% vitamin C by mass in the dossier; the remaining mass includes sodium. A Supplement Facts amount already declared as vitamin C must not be converted again. Buffered does not mean clinically superior. See the form-specific clinical note; tolerance depends on dose and medical context. |
Good option [LABEL // VERIFY_DOSE_BASIS] Approximately 89% vitamin C by mass in the dossier; the remaining mass includes sodium. A Supplement Facts amount already declared as vitamin C must not be converted again. Buffered does not mean clinically superior. |
| Liposomal vitamin C: declared vitamin mass Best for: Comparison with the exact ingredient and dose basis on the Supplement Facts panel. |
100% elemental / active | 500–500 mg | Enter declared vitamin C mg, not total phospholipid/product weight. A 500 mg trial reported about 27% higher plasma Cmax and 21% higher AUC; this is pharmacokinetics, not proof of better illness outcomes. See the form-specific clinical note; tolerance depends on dose and medical context. |
Good option [LABEL // VERIFY_DOSE_BASIS] Enter declared vitamin C mg, not total phospholipid/product weight. A 500 mg trial reported about 27% higher plasma Cmax and 21% higher AUC; this is pharmacokinetics, not proof of better illness outcomes. |
Common label traps
- TRAP_01 // Megadoses cure colds after symptoms start
Regular dosing modestly shortens duration; onset-after-symptoms studies do not show a consistent therapeutic effect. - TRAP_02 // Liposomal means dramatically better health outcomes
Modest exposure gains do not establish superior clinical outcomes or justify any particular price premium. - TRAP_03 // The excess is harmless because it leaves in urine
GI intolerance and oxalate/kidney concerns remain; dosing to diarrhea is not detoxification.
Other outcomes studied
Outside the five leaderboard goals. Same evidence levels as above.
- SCURVY Strong · benefit
Correction of vitamin C deficiency reverses scurvy; this established indication is distinct from cosmetic or energy claims.
PMID 33668681 PMID 29763052 - COLDS: REGULAR USE Moderate · benefit
About 8% shorter in adults and 14% in children with regular intake; incidence is generally unchanged, except a marked signal in extreme exertion/cold subgroups.
PMID 23440782 PMID 38082300 - COLDS: AFTER ONSET Limited · no benefit
No consistent shortening when supplementation starts after symptoms.
PMID 23440782 - BLOOD PRESSURE / ENDOTHELIUM Limited · benefit
Short trials suggest roughly 3.8/1.5 mmHg lower systolic/diastolic pressure around 500 mg/day, with heterogeneity. FMD improvements are surrogate findings, not proven prevention of infarction or death.
PMID 32080138 PMID 37791386 PMID 24792921 PMID 30683434 - TRAINING ADAPTATION Limited · makes it worse
High-dose C plus E blunted some mitochondrial markers and lean-mass responses; the contribution of C alone and lower doses remains uncertain.
PMID 24492839 PMID 26129928 PMID 26482865 - URATE VS GOUT Limited · benefit
A small serum urate reduction, about 0.35 mg/dL, does not establish fewer gout attacks or less pain.
PMID 21671418 PMID 34767649 - IV SEPSIS / CANCER Limited · no benefit
ICU reviews are conflicting and newer evidence does not establish mortality benefit; possible harm is noted in the dossier. VITALITY did not improve the overall primary progression-free survival endpoint with IV vitamin C. These are hospital interventions.
PMID 34495877 PMID 42384633 PMID 35929990 PMID 39076107 - SKIN / WOUNDS Limited · benefit
Collagen biochemistry and deficiency correction are established; extra oral C has weak evidence for better skin or wound outcomes in nourished people.
PMID 28805671 PMID 38345088 - PNEUMONIA / COVID-19 Limited · no benefit
Pneumonia evidence is insufficient; COVID-19 RCT reviews do not establish meaningful benefit.
PMID 34791642 PMID 38732592
Reader questions
Will it help if I take it when a cold starts?
The consistent small duration benefit comes from regular prior intake. Post-onset studies have not demonstrated a reliable rescue effect.
Which form is worth buying?
Ascorbic acid is the reference. Sodium or calcium ascorbate may be less acidic but add minerals. Liposomal forms alter exposure without established superior clinical outcomes.
Can I use bowel tolerance to find my dose?
Diarrhea is an adverse effect. It does not measure detoxification, cellular need or freedom from kidney risk.
Can it replace treatment for persistent illness or low mood?
No established evidence supports treating unexplained chronic symptoms, depression or serious infection this way. Catecholamine biochemistry is not proof that extra C helps a nourished person.
Stack interactions
- Caution Iron and iron overload [CAUTION // CLINICAL_REVIEW]
Vitamin C enhances non-heme iron absorption from a meal. In iron-deficiency anemia, an equivalence RCT found no extra hematologic benefit while a later meta-analysis suggested a benefit; routine add-on necessity remains unsettled. Avoid increasing iron absorption in overload.
PMID 33136134 PMID 40765927 - Caution High-dose vitamin E during training [CAUTION // CLINICAL_REVIEW]
Combined high doses impaired some cellular endurance adaptations and lean-mass gains in specific RCTs; these findings do not mean dietary antioxidants should be restricted.
PMID 24492839 PMID 26129928 PMID 26482865 - Caution Levothyroxine and glucose monitoring [CAUTION // CLINICAL_REVIEW]
The dossier flags increased levothyroxine absorption in some gastric contexts and interference with some glucose meters at high vitamin C exposure. Review the exact drug/device; the levothyroxine catalog metadata are incomplete. - Caution Warfarin and cancer treatment [CAUTION // CLINICAL_REVIEW]
Warfarin evidence is weak and the dossier interaction review is flagged for attribution review. Do not alter anticoagulants or add high-dose antioxidants during oncology care without the treating team.
Red flags: interactions and who should avoid it
Interactions
Iron and iron overload: Vitamin C enhances non-heme iron absorption from a meal. In iron-deficiency anemia, an equivalence RCT found no extra hematologic benefit while a later meta-analysis suggested a benefit; routine add-on necessity remains unsettled. Avoid increasing iron absorption in overload. High-dose vitamin E during training: Combined high doses impaired some cellular endurance adaptations and lean-mass gains in specific RCTs; these findings do not mean dietary antioxidants should be restricted. Levothyroxine and glucose monitoring: The dossier flags increased levothyroxine absorption in some gastric contexts and interference with some glucose meters at high vitamin C exposure. Review the exact drug/device; the levothyroxine catalog metadata are incomplete. Warfarin and cancer treatment: Warfarin evidence is weak and the dossier interaction review is flagged for attribution review. Do not alter anticoagulants or add high-dose antioxidants during oncology care without the treating team.
Avoid or ask a doctor first if
High doses need particular caution with calcium-oxalate stones, hyperoxaluria, kidney disease, iron overload or hemochromatosis. G6PD deficiency is a concern particularly with high-dose IV exposure. Pregnancy and lactation are not reasons to self-prescribe megadoses; diarrhea is an adverse effect, not a detox endpoint.
Sources (PubMed, 12)
- Vitamin C for preventing and treating the common cold.
PMID 23440782 · 2013 · Systematic review / meta-analysisCochrane review separates regular cold supplementation, general incidence and post-onset treatment.
- The Efficacy and Safety of Vitamin C for Iron Supplementation in Adult Patients With Iron Deficiency Anemia: A Randomized Clinical Trial.
PMID 33136134 · 2020 · Randomized controlled trialEquivalence RCT found no additional hematologic benefit from adding vitamin C to iron.
- Efficacy of vitamin C with Fe supplementation in patients with iron deficiency anemia: a systematic review and meta-analysis.
PMID 40765927 · 2024 · Systematic review / meta-analysisMeta-analysis reports a possible add-on benefit, conflicting with the equivalence RCT.
- Effects of vitamin C supplementation on essential hypertension: A systematic review and meta-analysis.
PMID 32080138 · 2020 · Systematic review / meta-analysisShort-term blood-pressure outcomes in supplementation RCTs.
- Vitamin C supplementation for the primary prevention of cardiovascular disease.
PMID 28301692 · 2017 · Systematic review / meta-analysisPrimary cardiovascular prevention review does not establish clinical-event benefit.
- Vitamin C and E supplementation hampers cellular adaptation to endurance training in humans: a double-blind, randomised, controlled trial.
PMID 24492839 · 2014 · Randomized controlled trialCombined C and E trial found impaired cellular endurance adaptations.
- Vitamin C and E supplementation blunts increases in total lean body mass in elderly men after strength training.
PMID 26129928 · 2016 · Randomized controlled trialCombined C and E trial reports smaller lean-mass gains in older men.
- Vitamin C pharmacokinetics: implications for oral and intravenous use.
PMID 15068981 · 2004 · Pharmacokinetic studyOral versus IV pharmacokinetics; oral dose cannot recreate IV exposure.
- Liposomal delivery enhances absorption of vitamin C into plasma and leukocytes: a double-blind, placebo-controlled, randomized trial.
PMID 39237620 · 2024 · Randomized controlled trial500 mg liposomal pharmacokinetic trial; not a clinical efficacy trial for colds.
- A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study).
PMID 35929990 · 2022 · Randomized controlled trialVITALITY phase III oncology study did not improve the overall primary progression-free survival endpoint.
- Vitamin C Status and Cognitive Function: A Systematic Review.
PMID 28867798 · 2017 · Systematic review / meta-analysisStatus/cognition systematic review; association is not supplementation efficacy.
- Dietary supplements for chronic gout.
PMID 34767649 · 2021 · Systematic review / meta-analysisGout review does not establish clinical benefit from small urate changes.
Community comments
No approved comments yet. Comments are held for moderation.